HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,411,834 | +2.8% | 36,959 | -2.9% | 0.02% | +25.0% |
| Q2 2023 | $1,372,788 | -8.9% | 38,059 | -3.5% | 0.02% | -15.8% |
| Q1 2023 | $1,506,939 | -34.2% | 39,459 | -1.9% | 0.02% | -36.7% |
| Q4 2022 | $2,289,827 | +43.8% | 40,243 | -0.1% | 0.03% | +30.4% |
| Q3 2022 | $1,592,000 | -11.0% | 40,265 | -0.9% | 0.02% | -14.8% |
| Q2 2022 | $1,788,000 | -0.4% | 40,629 | -9.7% | 0.03% | +50.0% |
| Q1 2022 | $1,795,000 | -3.2% | 44,998 | -2.4% | 0.02% | -10.0% |
| Q4 2021 | $1,854,000 | -4.2% | 46,098 | -3.1% | 0.02% | -9.1% |
| Q3 2021 | $1,935,000 | -6.7% | 47,558 | +4.1% | 0.02% | -4.3% |
| Q2 2021 | $2,074,000 | +17.6% | 45,675 | +8.0% | 0.02% | +9.5% |
| Q1 2021 | $1,763,000 | +8.9% | 42,281 | +11.5% | 0.02% | 0.0% |
| Q4 2020 | $1,619,000 | – | 37,911 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |